- 2024-08-20 01:58抑制剂INO-1001|INO-1001|501364-82-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:58抑制剂INO-1001|INO-1001|501364-82-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:58抑制剂IPA-3|IPA-3|42521-82-4|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:58抑制剂IPA-3|IPA-3|42521-82-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:58抑制剂INH1|INH1|313553-47-8|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:58抑制剂INH1|INH1|313553-47-8|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:58抑制剂INH1|INH1|313553-47-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:58抑制剂Infigratinib|Infigratinib|872511-34-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:58抑制剂Ingliforib|Ingliforib|186392-65-4|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:58抑制剂Ingliforib|Ingliforib|186392-65-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:58抑制剂Ingliforib|Ingliforib|186392-65-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:58抑制剂Indophagolin|Indophagolin|1207660-00-1|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:58抑制剂Infigratinib|Infigratinib|872511-34-7|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:58抑制剂Infigratinib|Infigratinib|872511-34-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:58抑制剂Indeglitazar|Indeglitazar|835619-41-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:58抑制剂Indisulam|Indisulam|165668-41-7|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:58抑制剂Indophagolin|Indophagolin|1207660-00-1|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:58抑制剂Indophagolin|Indophagolin|1207660-00-1|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:58抑制剂INCB086550|INCB086550|2230911-59-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:58抑制剂Indeglitazar|Indeglitazar|835619-41-5|Adamas life|≥98%（以实测数值为准）|BR|1mg
